Telo Genomics Corp.

Telo Genomics Corp.

TDSGF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.51M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Telo Genomics Corp.Telo Genomics Corp.-2-145%--0.9
$-0.01

Current Fair Value

130.8% downside

Overvalued by 130.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.51 Million
Enterprise Value$3.62 Million
Earnings per Share$-0.02
Beta0.24
Outstanding Shares100,430,472

Return

Return on Equity144.57%ROE
Return on Assets-381.40%
Return on Invested Capital140.44%

Valuation & Multiples

P/E Ratio-1.96P/E Ratio
PEG29.77PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.03Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-1.67
Enterprise Value to Net Income-2
Total Debt to Enterprise0.4
Debt to Equity-0.91Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 28, 2026
EPS
-$0.00
Reported
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
November 25, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Telo Genomics Corp.

8 employees
CEO: John Allen Farlinger

Telo Genomics Corp. is a biotechnology enterprise focused on developing and commercializing sophisticated predictive technologies. Their mission is to enable personalized treatment approaches for patients facing specific health challenge...

Questions & Answers